Skip to content
AI IntelligenceSep 2, 2026Primary Market
Article

Thyme Care · $125M · Series E

Thyme Care, a virtual cancer treatment navigation platform, closed a $125 million Series E funding round, pushing its post-money valuation above $2 billion. This represents a significant re-rating from its $1 billion+ valuation in 2025.

Data Cube AI EditorialSource: techmeme.com
01

Source Brief

Thyme Care, a virtual cancer treatment navigation platform, closed a $125 million Series E funding round, pushing its post-money valuation above $2 billion. This represents a significant re-rating from its $1 billion+ valuation in 2025.